 Laura Hurley
Concepts (223)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Physicians, Primary Care | 16 | 2024 | 235 | 3.970 |
Why?
| | Vaccination | 41 | 2025 | 1379 | 3.470 |
Why?
| | Practice Patterns, Physicians' | 25 | 2024 | 1302 | 2.500 |
Why?
| | Attitude of Health Personnel | 28 | 2024 | 1162 | 2.390 |
Why?
| | Vaccines | 14 | 2025 | 406 | 2.150 |
Why?
| | Health Knowledge, Attitudes, Practice | 13 | 2025 | 1327 | 2.140 |
Why?
| | Influenza Vaccines | 15 | 2024 | 539 | 2.020 |
Why?
| | Herpes Zoster Vaccine | 7 | 2022 | 159 | 1.950 |
Why?
| | Pneumococcal Vaccines | 6 | 2021 | 142 | 1.910 |
Why?
| | Physicians, Family | 11 | 2021 | 201 | 1.580 |
Why?
| | Influenza, Human | 11 | 2023 | 625 | 1.410 |
Why?
| | Herpes Zoster | 4 | 2022 | 316 | 1.380 |
Why?
| | Health Care Surveys | 13 | 2021 | 564 | 1.230 |
Why?
| | Immunization | 8 | 2021 | 411 | 1.110 |
Why?
| | Papillomavirus Vaccines | 8 | 2021 | 237 | 1.070 |
Why?
| | Immunization, Secondary | 1 | 2025 | 89 | 0.920 |
Why?
| | Immunization Schedule | 9 | 2021 | 197 | 0.910 |
Why?
| | Surveys and Questionnaires | 23 | 2025 | 5769 | 0.910 |
Why?
| | Primary Health Care | 10 | 2024 | 1724 | 0.880 |
Why?
| | Papillomavirus Infections | 5 | 2021 | 324 | 0.880 |
Why?
| | Physicians | 10 | 2022 | 907 | 0.880 |
Why?
| | Guideline Adherence | 4 | 2024 | 549 | 0.810 |
Why?
| | Vaccines, Synthetic | 2 | 2022 | 126 | 0.770 |
Why?
| | Diphtheria-Tetanus-acellular Pertussis Vaccines | 4 | 2019 | 91 | 0.750 |
Why?
| | Respiratory Function Tests | 1 | 2024 | 596 | 0.750 |
Why?
| | Pediatricians | 7 | 2022 | 129 | 0.750 |
Why?
| | Internal Medicine | 5 | 2014 | 253 | 0.730 |
Why?
| | General Practitioners | 2 | 2021 | 28 | 0.720 |
Why?
| | Asthma | 6 | 2025 | 2293 | 0.700 |
Why?
| | Adult | 45 | 2025 | 37724 | 0.700 |
Why?
| | Insurance, Health, Reimbursement | 4 | 2018 | 99 | 0.680 |
Why?
| | Reminder Systems | 3 | 2018 | 168 | 0.670 |
Why?
| | Vaccination Refusal | 5 | 2021 | 70 | 0.660 |
Why?
| | Patient Protection and Affordable Care Act | 2 | 2016 | 103 | 0.610 |
Why?
| | Middle Aged | 39 | 2025 | 33310 | 0.610 |
Why?
| | Respiratory Syncytial Virus Vaccines | 1 | 2018 | 36 | 0.590 |
Why?
| | Family Practice | 10 | 2017 | 462 | 0.560 |
Why?
| | United States | 35 | 2025 | 14742 | 0.560 |
Why?
| | Pneumococcal Infections | 2 | 2018 | 115 | 0.550 |
Why?
| | Immunization Programs | 6 | 2020 | 213 | 0.540 |
Why?
| | Respiratory Syncytial Virus Infections | 1 | 2018 | 128 | 0.540 |
Why?
| | Practice Guidelines as Topic | 8 | 2024 | 1577 | 0.520 |
Why?
| | Humans | 78 | 2025 | 137294 | 0.520 |
Why?
| | Clinical Competence | 3 | 2018 | 1100 | 0.490 |
Why?
| | Female | 48 | 2025 | 73052 | 0.470 |
Why?
| | Male | 43 | 2025 | 67560 | 0.440 |
Why?
| | Preventive Health Services | 1 | 2016 | 148 | 0.430 |
Why?
| | Insurance, Health | 1 | 2016 | 280 | 0.420 |
Why?
| | Pediatrics | 11 | 2021 | 1113 | 0.420 |
Why?
| | Diabetes Mellitus | 1 | 2022 | 1036 | 0.410 |
Why?
| | Aged | 17 | 2025 | 23851 | 0.390 |
Why?
| | Meningococcal Vaccines | 3 | 2018 | 55 | 0.370 |
Why?
| | Mumps | 2 | 2022 | 25 | 0.370 |
Why?
| | Medicare Part D | 1 | 2010 | 25 | 0.330 |
Why?
| | Health Services Research | 2 | 2018 | 402 | 0.330 |
Why?
| | Age Factors | 8 | 2021 | 3297 | 0.330 |
Why?
| | Clinical Decision-Making | 3 | 2021 | 319 | 0.320 |
Why?
| | Anti-Asthmatic Agents | 2 | 2025 | 393 | 0.310 |
Why?
| | Rotavirus Vaccines | 3 | 2021 | 46 | 0.300 |
Why?
| | Nephrology | 1 | 2009 | 61 | 0.290 |
Why?
| | Neuralgia, Postherpetic | 1 | 2008 | 40 | 0.280 |
Why?
| | Minority Groups | 1 | 2010 | 267 | 0.280 |
Why?
| | Rotavirus Infections | 2 | 2021 | 43 | 0.280 |
Why?
| | Gynecology | 3 | 2019 | 176 | 0.280 |
Why?
| | Emigrants and Immigrants | 1 | 2009 | 139 | 0.260 |
Why?
| | Adrenal Cortex Hormones | 3 | 2025 | 556 | 0.250 |
Why?
| | Cross-Sectional Studies | 5 | 2025 | 5436 | 0.240 |
Why?
| | Medicaid | 3 | 2025 | 434 | 0.240 |
Why?
| | Self Report | 4 | 2024 | 826 | 0.240 |
Why?
| | Meningococcal Infections | 2 | 2018 | 25 | 0.240 |
Why?
| | Vaccines, Conjugate | 2 | 2018 | 65 | 0.230 |
Why?
| | Pregnancy Complications, Infectious | 2 | 2020 | 389 | 0.220 |
Why?
| | Professional-Family Relations | 2 | 2016 | 142 | 0.220 |
Why?
| | Physician-Patient Relations | 3 | 2019 | 548 | 0.220 |
Why?
| | Vaccination Coverage | 1 | 2025 | 82 | 0.220 |
Why?
| | Adolescent | 13 | 2025 | 21499 | 0.220 |
Why?
| | Adverse Drug Reaction Reporting Systems | 1 | 2024 | 77 | 0.210 |
Why?
| | Health Expenditures | 1 | 2025 | 185 | 0.210 |
Why?
| | Data Mining | 1 | 2024 | 117 | 0.210 |
Why?
| | Tinnitus | 1 | 2024 | 57 | 0.210 |
Why?
| | Kidney Failure, Chronic | 1 | 2009 | 566 | 0.200 |
Why?
| | Young Adult | 7 | 2025 | 13163 | 0.200 |
Why?
| | Beclomethasone | 1 | 2022 | 27 | 0.190 |
Why?
| | Behavioral Risk Factor Surveillance System | 1 | 2022 | 51 | 0.190 |
Why?
| | Rubella | 1 | 2022 | 24 | 0.190 |
Why?
| | Neisseria meningitidis, Serogroup B | 2 | 2018 | 16 | 0.190 |
Why?
| | Measles | 1 | 2022 | 46 | 0.180 |
Why?
| | Electronic Health Records | 3 | 2025 | 1045 | 0.180 |
Why?
| | Herpesvirus 3, Human | 2 | 2019 | 332 | 0.180 |
Why?
| | Child | 15 | 2025 | 21999 | 0.180 |
Why?
| | Refusal to Treat | 1 | 2020 | 17 | 0.170 |
Why?
| | Pregnancy | 6 | 2025 | 6743 | 0.170 |
Why?
| | Insurance Coverage | 3 | 2018 | 229 | 0.170 |
Why?
| | Standing Orders | 1 | 2020 | 11 | 0.170 |
Why?
| | Norovirus | 1 | 2020 | 26 | 0.160 |
Why?
| | Advisory Committees | 1 | 2021 | 219 | 0.160 |
Why?
| | Policy | 1 | 2020 | 150 | 0.160 |
Why?
| | Obstetrics | 2 | 2019 | 163 | 0.150 |
Why?
| | Gastroenteritis | 1 | 2020 | 68 | 0.150 |
Why?
| | Cost of Illness | 2 | 2018 | 303 | 0.150 |
Why?
| | Evidence-Based Medicine | 2 | 2020 | 740 | 0.150 |
Why?
| | Influenza A Virus, H1N1 Subtype | 1 | 2020 | 152 | 0.150 |
Why?
| | Respiratory Syncytial Virus, Human | 1 | 2018 | 75 | 0.140 |
Why?
| | Awareness | 1 | 2018 | 105 | 0.140 |
Why?
| | Professional Practice | 1 | 2018 | 64 | 0.140 |
Why?
| | Administration, Inhalation | 3 | 2025 | 683 | 0.140 |
Why?
| | Glucocorticoids | 1 | 2022 | 596 | 0.140 |
Why?
| | Cardiovascular Diseases | 1 | 2010 | 2113 | 0.140 |
Why?
| | Patients | 1 | 2018 | 174 | 0.130 |
Why?
| | Hepatitis A | 1 | 2017 | 26 | 0.130 |
Why?
| | Health Plan Implementation | 1 | 2018 | 139 | 0.130 |
Why?
| | Physician's Role | 2 | 2019 | 210 | 0.130 |
Why?
| | Information Systems | 1 | 2016 | 61 | 0.130 |
Why?
| | Quality of Life | 3 | 2023 | 2885 | 0.130 |
Why?
| | Directive Counseling | 1 | 2016 | 46 | 0.120 |
Why?
| | Text Messaging | 1 | 2018 | 156 | 0.120 |
Why?
| | Self-Management | 1 | 2018 | 166 | 0.120 |
Why?
| | Parents | 4 | 2021 | 1357 | 0.120 |
Why?
| | Colorado | 4 | 2019 | 4527 | 0.120 |
Why?
| | Treatment Refusal | 1 | 2015 | 89 | 0.120 |
Why?
| | Patient Acceptance of Health Care | 3 | 2016 | 808 | 0.110 |
Why?
| | Attitude to Health | 1 | 2017 | 440 | 0.110 |
Why?
| | Medicare | 2 | 2018 | 758 | 0.110 |
Why?
| | Infant | 7 | 2025 | 9451 | 0.110 |
Why?
| | Health Care Costs | 1 | 2017 | 387 | 0.110 |
Why?
| | Chi-Square Distribution | 2 | 2018 | 533 | 0.110 |
Why?
| | Documentation | 1 | 2015 | 191 | 0.110 |
Why?
| | Medically Uninsured | 1 | 2014 | 129 | 0.100 |
Why?
| | Health Surveys | 2 | 2018 | 517 | 0.100 |
Why?
| | Tumor Microenvironment | 1 | 2017 | 674 | 0.100 |
Why?
| | Neoplastic Stem Cells | 1 | 2017 | 400 | 0.100 |
Why?
| | Interdisciplinary Communication | 1 | 2014 | 192 | 0.100 |
Why?
| | Fibroblasts | 1 | 2017 | 993 | 0.090 |
Why?
| | Neisseria meningitidis | 1 | 2011 | 23 | 0.090 |
Why?
| | Safety | 1 | 2013 | 343 | 0.090 |
Why?
| | Fees, Pharmaceutical | 1 | 2010 | 9 | 0.080 |
Why?
| | Internet | 2 | 2019 | 651 | 0.080 |
Why?
| | Hepatitis B Vaccines | 1 | 2009 | 45 | 0.080 |
Why?
| | Data Collection | 4 | 2014 | 669 | 0.080 |
Why?
| | Mexican Americans | 1 | 2010 | 120 | 0.070 |
Why?
| | Aged, 80 and over | 2 | 2011 | 7607 | 0.070 |
Why?
| | Hepatitis B | 1 | 2009 | 70 | 0.070 |
Why?
| | Referral and Consultation | 1 | 2014 | 778 | 0.070 |
Why?
| | ROC Curve | 1 | 2010 | 548 | 0.070 |
Why?
| | Kaplan-Meier Estimate | 1 | 2010 | 892 | 0.070 |
Why?
| | Regression Analysis | 2 | 2020 | 1028 | 0.070 |
Why?
| | Electronic Mail | 2 | 2018 | 61 | 0.070 |
Why?
| | Health Personnel | 3 | 2019 | 704 | 0.070 |
Why?
| | Costs and Cost Analysis | 2 | 2018 | 205 | 0.070 |
Why?
| | Proportional Hazards Models | 1 | 2010 | 1260 | 0.060 |
Why?
| | Kidney Diseases | 1 | 2009 | 406 | 0.060 |
Why?
| | Renal Dialysis | 1 | 2009 | 435 | 0.060 |
Why?
| | Risk Assessment | 2 | 2015 | 3439 | 0.060 |
Why?
| | Predictive Value of Tests | 1 | 2010 | 2032 | 0.060 |
Why?
| | Seasons | 2 | 2020 | 545 | 0.050 |
Why?
| | Vaccines, Combined | 1 | 2023 | 48 | 0.050 |
Why?
| | Nebulizers and Vaporizers | 1 | 2023 | 86 | 0.050 |
Why?
| | Bacterial Vaccines | 1 | 2023 | 63 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2024 | 401 | 0.050 |
Why?
| | Time Factors | 2 | 2010 | 6818 | 0.050 |
Why?
| | Measles-Mumps-Rubella Vaccine | 1 | 2022 | 42 | 0.050 |
Why?
| | Symptom Flare Up | 1 | 2022 | 41 | 0.050 |
Why?
| | Incidence | 2 | 2024 | 2808 | 0.050 |
Why?
| | Mumps Vaccine | 1 | 2021 | 13 | 0.050 |
Why?
| | Kidney | 1 | 2009 | 1467 | 0.050 |
Why?
| | Delivery of Health Care | 1 | 2009 | 944 | 0.050 |
Why?
| | Risk Factors | 3 | 2010 | 10368 | 0.040 |
Why?
| | Vaccines, Inactivated | 1 | 2021 | 68 | 0.040 |
Why?
| | Qualitative Research | 2 | 2018 | 1367 | 0.040 |
Why?
| | Hypertension | 1 | 2009 | 1285 | 0.040 |
Why?
| | Vaccines, Attenuated | 1 | 2021 | 131 | 0.040 |
Why?
| | Child, Preschool | 3 | 2025 | 11080 | 0.040 |
Why?
| | Attitude | 1 | 2021 | 260 | 0.040 |
Why?
| | Pandemics | 2 | 2021 | 1623 | 0.040 |
Why?
| | Disease Outbreaks | 1 | 2022 | 384 | 0.040 |
Why?
| | Postal Service | 1 | 2018 | 32 | 0.040 |
Why?
| | Serogroup | 1 | 2018 | 44 | 0.040 |
Why?
| | Pharmacists | 1 | 2021 | 260 | 0.040 |
Why?
| | Diphtheria | 1 | 2017 | 20 | 0.040 |
Why?
| | Tetanus | 1 | 2017 | 25 | 0.040 |
Why?
| | Whooping Cough | 1 | 2017 | 51 | 0.030 |
Why?
| | Population Groups | 1 | 2017 | 62 | 0.030 |
Why?
| | Research Design | 1 | 2024 | 1128 | 0.030 |
Why?
| | Safety-net Providers | 1 | 2018 | 117 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2020 | 1521 | 0.030 |
Why?
| | Professional Practice Gaps | 1 | 2016 | 15 | 0.030 |
Why?
| | Equipment and Supplies | 1 | 2015 | 42 | 0.030 |
Why?
| | Mice, Nude | 1 | 2017 | 696 | 0.030 |
Why?
| | Hospitalization | 1 | 2025 | 2214 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2023 | 2839 | 0.030 |
Why?
| | Focus Groups | 1 | 2017 | 515 | 0.030 |
Why?
| | Mice, Inbred BALB C | 1 | 2017 | 1269 | 0.030 |
Why?
| | Induced Pluripotent Stem Cells | 1 | 2017 | 251 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2021 | 2850 | 0.030 |
Why?
| | Sex Factors | 1 | 2019 | 2073 | 0.030 |
Why?
| | Communication | 1 | 2019 | 879 | 0.030 |
Why?
| | Circovirus | 1 | 2013 | 7 | 0.030 |
Why?
| | Decision Support Systems, Clinical | 1 | 2016 | 222 | 0.030 |
Why?
| | Intussusception | 1 | 2013 | 28 | 0.030 |
Why?
| | Life Style | 1 | 2015 | 488 | 0.020 |
Why?
| | Societies, Medical | 1 | 2017 | 822 | 0.020 |
Why?
| | Drug Contamination | 1 | 2013 | 53 | 0.020 |
Why?
| | Product Surveillance, Postmarketing | 1 | 2013 | 63 | 0.020 |
Why?
| | Professional Practice Location | 1 | 2011 | 29 | 0.020 |
Why?
| | Community-Institutional Relations | 1 | 2012 | 98 | 0.020 |
Why?
| | Health Services Accessibility | 1 | 2019 | 982 | 0.020 |
Why?
| | Swine | 1 | 2013 | 774 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2025 | 10800 | 0.020 |
Why?
| | Infant, Newborn | 1 | 2021 | 6054 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2017 | 4197 | 0.020 |
Why?
| | Cell Differentiation | 1 | 2017 | 1987 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2017 | 3414 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2018 | 5125 | 0.020 |
Why?
| | Diabetes Complications | 1 | 2009 | 226 | 0.020 |
Why?
| | Vascular Diseases | 1 | 2009 | 244 | 0.020 |
Why?
| | Risk-Taking | 1 | 2009 | 349 | 0.020 |
Why?
| | Glomerular Filtration Rate | 1 | 2009 | 745 | 0.020 |
Why?
| | Logistic Models | 1 | 2009 | 2071 | 0.010 |
Why?
| | Chronic Disease | 1 | 2009 | 1788 | 0.010 |
Why?
| | Animals | 2 | 2017 | 36862 | 0.010 |
Why?
| | Mice | 1 | 2017 | 17774 | 0.010 |
Why?
| | Cohort Studies | 1 | 2009 | 5726 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2009 | 15639 | 0.010 |
Why?
|
|
Hurley's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|